Browsing Centre for Immunobiology by Subject "FRAX"
Now showing items 1-2 of 2
-
Assessment of bone mineral density in tenofovir-treated patients with chronic hepatitis B: can the fracture risk assessment tool identify those at greatest risk?.
(Oxford University Press, 2014-08-25)Abstract BACKGROUND: Tenofovir disoproxil fumarate (TDF) is an established nucleotide analogue in the treatment of chronic hepatitis B. Bone mineral density loss has been described in TDF-treated patients with human ...